Figure S1 TCM preparation (A) C26 cells (0.5×10 6 ), in 100 μl of sterile PBS, were subcutaneously inoculated into the dorsal region of CD2F1 mice. The image demonstrates tumour development on day 10. (B) A photograph displaying the resected tumour collected from the CD2F1 mice. (C) The C26 tumour was diced and placed in serum-free DMEM for TCM collection. (D) A 4-12 % NuPAGE gel stained with Coomassie Brilliant Blue displaying the proteins found in the lysate and CM from C26 cells and C26 tumours.
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Figure S4 Schematic diagram summarizing cancer-induced cachexia in skeletal muscle
The C26 tumour produces several effectors, including Mstn, activin A and other tumoral cytokines, which impart deleterious consequences on skeletal muscle. Mstn family members present in the C26 CM may prevent the proliferation and myogenesis of myoblasts. Furthermore, components in C26 CM also induced the activity of NF-κB and FoxO transcription factors, but inhibited Akt. Collectively, these signalling molecules are involved in regulating the activity of degradative pathways. Indeed, C2C12 muscle cell cultures exposed to C26 CM displayed the elevated activity of the ubiquitin-proteasome and the autophagy-lysosome pathway. Moreover, the C26 CM also increased oxidative stress and induced mitochondrial dysfunction in muscle cell cultures. Finally, selective inhibition of Mstn in the C26 CM demonstrated a greater rescue of the atrophy phenotype compared with selective activin A inhibition. Thus Mstn secretion by C26 may play a principal role in the pathogenesis of C26-induced cancer cachexia. The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited. 
